Edwards Lifesciences (EW) Offers Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall St futures subdued as Nvidia results, inflation take center stage
- Oil drops to more than two-week low on hopes of Hormuz reopening
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Boston Scientific discloses cybersecurity incident causing global disruption
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
Cowen Reiterates Outperform on Edwards Lifesciences (EW)
December 10, 2018 8:18 AM ESTCowen analyst, Joshua Jennings, reiterated an Outperform rating and $190.00 price target on Edwards Lifesciences (NYSE: EW). Jennings views the 4Q18 setup favorably and expects EW to accelerate TAVR sales growth in 2019. Cowen thinks last weeks investor conference justifies bullishness about the growth... More
Edwards Lifesciences (EW) PT Raised to $175 at RBC Capital
December 6, 2018 7:15 AM ESTRBC Capital analyst Glenn Novarro raised the price target on Edwards Lifesciences (NYSE: EW) to $175.00 (from $153.00) while maintaining a Outperform rating.
The firm is increasing EPS estimates for 2019 and 2020 on the basis of higher gross margin and lower tax rate assumptions.
... More